165 related articles for article (PubMed ID: 36357137)
1. Treating Myocardial Inflammation in Cardiac Sarcoidosis: Why, With What, and for How Long?
Blankstein R; Divakaran S
JACC Cardiovasc Imaging; 2022 Nov; 15(11):1956-1959. PubMed ID: 36357137
[No Abstract] [Full Text] [Related]
2. Fluorodeoxyglucose Myocardial Accumulation to Assess Response to Immunosuppressive Treatment in Cardiac Sarcoidosis.
Cooper LT; Reddy P
JACC Cardiovasc Imaging; 2024 Jan; 17(1):59-61. PubMed ID: 37656116
[No Abstract] [Full Text] [Related]
3. Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis.
Kruse MJ; Kovell L; Kasper EK; Pomper MG; Moller DR; Solnes L; Chen ES; Schindler TH
JACC Cardiovasc Imaging; 2017 Feb; 10(2):157-167. PubMed ID: 28109920
[TBL] [Abstract][Full Text] [Related]
4. Effect of Corticosteroid Dose and Duration on 18-Fluorodeoxyglucose Positron Emission Tomography in Cardiac Sarcoidosis.
Okada DR; Saad E; Wand AL; Griffin JM; Kasper EK; Chen EH; Chrispin J; Tandri H; Solnes LB; Gilotra NA
JACC Cardiovasc Imaging; 2020 May; 13(5):1280-1282. PubMed ID: 31954655
[No Abstract] [Full Text] [Related]
5. Cardiac sarcoidosis: the complementary role of 18F-FDG PET and MRI.
Van Schandevyl S; Waterschoot R; De Vos N; Devos D; Goethals I
J Cardiovasc Med (Hagerstown); 2020 Apr; 21(4):335-336. PubMed ID: 31809284
[No Abstract] [Full Text] [Related]
6. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
[TBL] [Abstract][Full Text] [Related]
7. Malfunctioned cardiac resynchronization therapy attributed to acute exacerbation of cardiac sarcoidosis.
Ikeda S; Ohtani K; Uwatoku T; Higo T
Eur Heart J; 2016 Sep; 37(33):2613. PubMed ID: 27225198
[No Abstract] [Full Text] [Related]
8. Detection of Active Inflammation Status Around Ventricular Aneurysms in Patients With Cardiac Sarcoidosis.
Nanno T; Kobayashi S; Yoshitomi R; Fujii S; Kajii T; Kohno M; Ishiguchi H; Okuda S; Okada M; Suga K; Yano M
Circ J; 2019 Nov; 83(12):2494-2504. PubMed ID: 31631075
[TBL] [Abstract][Full Text] [Related]
9. Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis.
Rojulpote C; Bhattaru A; Jean C; Adams SL; Patel V; Vidula MK; Selvaraj S; Dubroff J; Peyster E; Clancy CB; Patterson K; Marchlinski FE; Rossman M; Goldberg L; Bravo PE
JACC Cardiovasc Imaging; 2022 Nov; 15(11):1944-1955. PubMed ID: 36357136
[TBL] [Abstract][Full Text] [Related]
10. Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy.
Tadamura E; Yamamuro M; Kubo S; Kanao S; Hosokawa R; Kimura T; Kita T; Togashi K
Circulation; 2006 May; 113(20):e771-3. PubMed ID: 16717157
[No Abstract] [Full Text] [Related]
11. Pre-Treatment Myocardial
Subramanian M; Swapna N; Ali AZ; Saggu DK; Yalagudri S; Kishore J; Swamy LTN; Narasimhan C
JACC Cardiovasc Imaging; 2021 Oct; 14(10):2008-2016. PubMed ID: 33454258
[TBL] [Abstract][Full Text] [Related]
12. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
Paz YE; Bokhari S
Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
[TBL] [Abstract][Full Text] [Related]
13. PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection).
Manapragada PP; Andrikopoulou E; Bajaj N; Bhambhvani P
Radiol Clin North Am; 2021 Sep; 59(5):835-852. PubMed ID: 34392922
[TBL] [Abstract][Full Text] [Related]
14. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
Skali H; Schulman AR; Dorbala S
Curr Cardiol Rep; 2013 May; 15(5):352. PubMed ID: 23504346
[TBL] [Abstract][Full Text] [Related]
15. Infectious Myocarditis on FDG-PET Imaging Mimicking Sarcoidosis.
Sperry BW; Oldan JD; Hsich EM; Reynolds JP; Tamarappoo BK
J Nucl Cardiol; 2015 Aug; 22(4):840-4. PubMed ID: 25968627
[TBL] [Abstract][Full Text] [Related]
16. Prospective Analysis of Immunosuppressive Therapy in Cardiac Sarcoidosis With Fluorodeoxyglucose Myocardial Accumulation: The PRESTIGE Study.
Morimoto R; Unno K; Fujita N; Sakuragi Y; Nishimoto T; Yamashita M; Kuwayama T; Hiraiwa H; Kondo T; Kuwatsuka Y; Okumura T; Ohshima S; Takahashi H; Ando M; Ishii H; Kato K; Murohara T
JACC Cardiovasc Imaging; 2024 Jan; 17(1):45-58. PubMed ID: 37452820
[TBL] [Abstract][Full Text] [Related]
17. Imaging Cardiac Sarcoidosis With FLT-PET Compared With FDG/Perfusion-PET: A Prospective Pilot Study.
Martineau P; Pelletier-Galarneau M; Juneau D; Leung E; Nery PB; de Kemp R; Beanlands R; Birnie D
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 1):2280-2281. PubMed ID: 31422126
[No Abstract] [Full Text] [Related]
18. The role of positron emission tomography in the assessment of cardiac sarcoidosis.
Genovesi D; Bauckneht M; Altini C; Popescu CE; Ferro P; Monaco L; Borra A; Ferrari C; Caobelli F
Br J Radiol; 2019 Aug; 92(1100):20190247. PubMed ID: 31166768
[TBL] [Abstract][Full Text] [Related]
19. Repeatability and Optimization of FDG Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis.
Alvi RM; Young BD; Shahab Z; Pan H; Winkler J; Herzog E; Miller EJ
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1284-1287. PubMed ID: 30846271
[No Abstract] [Full Text] [Related]
20. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T
JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
